The role of crystalline lens power as a primary driver of refractive error in laser-treated ROP

Article

The spherical equivalent was significantly more myopic in the eyes treated with laser in a recent study.

©Iryna / stock.adobe.com
Researchers conducted a study of the effect of the number of applied laser shots on myopic variables in eyes with retinopathy of prematurity after laser treatment. (Image credit ©Iryna / stock.adobe.com)

A study that investigated various parameters associated with myopia compared eyes with retinopathy of prematurity (ROP) that were treated with laser and age-matched control eyes without ROP and found that the spherical equivalent (SE) was significantly more myopic in the eyes treated with laser.

However, only the crystalline lens power (CLP) among the parameters under study was associated with the number of laser shots applied,1 according to Dr Shotaro Asano, the lead study author from the Department of Ophthalmology, The University of Tokyo, Tokyo, and the Department of Ophthalmology, Asahi General Hospital, Asahi, Chiba, Japan.

Dr Asano and his colleagues undertook a study of the effect of the number of applied laser shots on these myopic variables in eyes with ROP after laser treatment (33 eyes of 17 infants). The variables included were the axial length (AL), corneal refraction (CR) and CLP. The findings were compared with the control group (14 eyes of 7 infants).

The authors reported that the SE was significantly more myopic in the ROP group (P < .001), although there was no significant difference between the groups in the AL.

They found that the SE was associated with AL, CR, and CLP in the ROP group. Of those 3 parameters, the CLP and the number of laser shots applied were correlated significantly (P = .003); but no correlations were found between the number of laser shots and the AL or CR (P = .15 and P = .10, respectively). They also reported this same similar tendency in the analysis of the difference between the right and left eyes of each child.

The authors concluded, “The SE value was significantly more myopic in the laser-treated ROP group compared to the control group. In the laser-treated ROP eyes, the SE value was related to the CR, AL, and CLP. The number of laser shots was associated with the CLP, but not with AL and CR, suggesting that the CLP was the primary component of the refractive error in the laser-treated ROP eyes.”

Reference
  1. Asano S, Inoue T, Kure K, et al. Investigating the factors affecting myopia in retinopathy of prematurity after laser treatment. Int J Retin Vitr. 2023; published online April 12; https://doi.org/10.1186/s40942-023-00456-x

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.